Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Implantica Q2 2026 Results Presentation
Business earnings call

Implantica Q2 2026 Results Presentation

Analysis based on 6 articles · First reported Aug 14, 2026 · Last updated Aug 14, 2026

Sentiment
0
Attention
0
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The announcement is a routine scheduling notice for Implantica's Q2 2026 earnings release and investor presentation. Market impact is expected to be minimal, with attention focused on the actual results and any forward-looking statements during the presentation.

Medical Devices
Event Summary

Implantica AG (publ), a medtech company listed on Nasdaq First North Premier Growth Market, announced that it will publish its interim report for the second quarter of 2026 on August 21, 2026, at 8:00 a.m. CEST, followed by a presentation at 15:00 CEST the same day. The presentation will be held in English via webcast and teleconference, featuring CEO Peter Forsell, CFO Andreas Ohrnberg, and Chief Corporate Affairs Officer Nicole Pehrsson. The company highlighted its lead product RefluxStop, a CE-marked implant for treating gastroesophageal reflux disease (GERD), and its pipeline including eHealth and wireless energizing platforms. This event is a routine quarterly earnings announcement and investor presentation, providing an update on the company's financial performance and business outlook.

Entities Involved
stock
Implantica
Implantica is the company hosting the Q2 2026 earnings presentation. The event provides an opportunity for the company to communicate its financial results and strategic progress to investors.
Importance 100.0 Sentiment 0.0
per
Peter Forsell
Peter Forsell, CEO of Implantica, is scheduled to speak at the Q2 2026 presentation, representing the company's leadership and discussing results.
Importance 60.0 Sentiment 0.0
per
Andreas Ohrnberg
Andreas Ohrnberg, CFO of Implantica, is scheduled to speak at the Q2 2026 presentation, providing financial details.
Importance 40.0 Sentiment 0.0
per
Nicole Pehrsson
Nicole Pehrsson, Chief Corporate Affairs Officer and Investor Relations contact, is scheduled to speak and is the point of contact for investor inquiries.
Importance 30.0 Sentiment 0.0
exch
Nasdaq First North Premier Growth Market
Nasdaq First North Premier Growth Market is the listing venue for Implantica, where the company's shares are traded. The event is part of the exchange's regular reporting cycle.
Importance 20.0 Sentiment 0.0
priv
FNCA Sweden AB
FNCA Sweden AB serves as Implantica's Certified Adviser, a regulatory role on the Nasdaq First North market. The event does not directly affect FNCA.
Importance 10.0 Sentiment 0.0
Relationships
Implantica related ↔ Nasdaq First North Premier Growth Market
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.